Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Annemiek Walenkamp-Hageman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study
van der Weide, H. L., Buunk, A. M., Siebenga, F. F., Langendijk, J. A., Bannink-Gawryszuk, A., Bosma, I., Enting, R. H., van der Hoorn, A., Jeltema, H. R., Wagemakers, M., Groen, R. J. M., Walenkamp-Hageman, A. M. E., Nuver, J., Kramer, M. C. A. & Spikman, J. M., 20-Feb-2025, (E-pub ahead of print) In: Journal of Neuro-Oncology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Downloads (Pure) -
Physical Activity Program among Cancer Survivors in General Practice: Evaluating Patient Outcomes
Huizinga, F., Westerink, N.-D. L., Walenkamp, A. M. E., Berendsen, A. J., de Greef, M. H. G., de Boer, M., de Bock, G., Berger, M. & Brandenbarg, D., 5-Mar-2025, (E-pub ahead of print) In: British Journal of General Practice.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Cancer survivors' experiences of a physical activity program in primary care: a qualitative study
Huizinga, F., Kieboom, E. A. M., de Greef, M. H. G., Walenkamp, A. M. E., Berendsen, A. J., Berger, M. Y. & Brandenbarg, D., 22-Mar-2024, (E-pub ahead of print) In: Journal of cancer survivorship-Research and practice. 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)23 Downloads (Pure) -
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
EORTC Brain Tumor Group, Canadian Cancer Trials Group, Roth, P., Gorlia, T., Reijneveld, J. C., de Vos, F., Idbaih, A., Frenel, J. S., Rhun, E. L., Sepulveda, J. M., Perry, J., Masucci, G. L., Freres, P., Hirte, H., Seidel, C., Walenkamp, A., Lukacova, S., Meijnders, P., Blais, A. & Ducray, F. & 12 others, , 1-Sept-2024, In: Neuro-Oncology. 26, 9, p. 1670-1682 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile11 Citations (Scopus)58 Downloads (Pure) -
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
Malta, T. M., Sabedot, T. S., Morosini, N. S., Datta, I., Garofano, L., Vallentgoed, W., Varn, F. S., Aldape, K., D'Angelo, F., Bakas, S., Barnholtz-Sloan, J. S., Gan, H. K., Hasanain, M., Hau, A. C., Johnson, K. C., Cazacu, S., deCarvalho, A. C., Khasraw, M., Kocakavuk, E. & Kouwenhoven, M. C. M. & 23 others, , 1-Mar-2024, In: Cancer Research. 84, 5, p. 741-756 16 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Citations (Scopus)79 Downloads (Pure)
Activities
-
The value of circulating tumour DNA in neuroendocrine neoplasms
Walenkamp-Hageman, A. (Invited speaker)
14-Sept-2024Activity: Talk and presentation › Professional or public presentation › Professional
-
ESMO Congress 2024
Walenkamp-Hageman, A. (Member of scientific committee)
2024 → …Activity: Organising and attending an event › Organising and contributing to an event › Academic
-
Dutch Brain Tumor Registry (External organisation)
Walenkamp-Hageman, A. (Member of board)
2024 → …Activity: Membership › Professional
-
College ter Beoordeling van Geneesmiddelen (External organisation)
Walenkamp-Hageman, A. (Member of board)
2024 → …Activity: Membership › Professional
-
Infrastructure for cancer care in Europe
Walenkamp-Hageman, A. (Invited speaker)
3-Oct-2024Activity: Talk and presentation › Academic presentation › Academic
Datasets
-
Additional file 7 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Schröder, C. (Contributor), van Rooijen, J. (Contributor), Walenkamp-Hageman, A. (Contributor), Van Deurzen, C. H. M. (Contributor), Qiu, S. (Contributor), de Vries, L. (Contributor), de Bock, T. (Contributor), Nienhuis, H. (Contributor), Timmer-Bosscha, H. (Contributor), van der Vegt, B. (Contributor) & Van Leeuwen-Stok, E. (Contributor), University of Groningen, 19-Mar-2020
DOI: 10.6084/m9.figshare.12004506.v1
Dataset
-
Additional file 10 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Keller, M. A. (Contributor), Wolf, D. (Contributor), Schäfer, G. (Contributor), Haybaeck, J. (Contributor), Daum, S. (Contributor), Krogsdam, A. (Contributor), Klocker, H. (Contributor), Pircher, A. (Contributor), Noureen, A. (Contributor), Plattner, C. (Contributor), Timmer-Bosscha, H. (Contributor), Goveia, J. (Contributor), Salcher, S. (Contributor), Walenkamp, A. (Contributor), Beatovic, A. (Contributor), Sopper, S. (Contributor), Trajanoski, Z. (Contributor), Moisse, M. (Contributor), Thaler, S. (Contributor) & Perner, S. (Contributor), figshare Academic Research System, 19-Jun-2022
DOI: 10.6084/m9.figshare.20098784.v1
Dataset
-
Additional file 4 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Nienhuis, H. (Contributor), Van Leeuwen-Stok, E. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), Qiu, S. (Contributor), Van Deurzen, C. H. M. (Contributor), Timmer-Bosscha, H. (Contributor), de Vries, L. (Contributor), Walenkamp-Hageman, A. (Contributor) & Schröder, C. (Contributor), University of Groningen, 19-Mar-2020
DOI: 10.6084/m9.figshare.12004491.v1
Dataset
-
Additional file 6 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Moisse, M. (Contributor), Trajanoski, Z. (Contributor), Thaler, S. (Contributor), Schäfer, G. (Contributor), Walenkamp, A. (Contributor), Daum, S. (Contributor), Sopper, S. (Contributor), Timmer-Bosscha, H. (Contributor), Pircher, A. (Contributor), Haybaeck, J. (Contributor), Krogsdam, A. (Contributor), Klocker, H. (Contributor), Goveia, J. (Contributor), Beatovic, A. (Contributor), Noureen, A. (Contributor), Keller, M. A. (Contributor), Wolf, D. (Contributor), Plattner, C. (Contributor), Salcher, S. (Contributor) & Perner, S. (Contributor), figshare Academic Research System, 19-Jun-2022
DOI: 10.6084/m9.figshare.20098802.v1
Dataset
-
Additional file 5 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Van Deurzen, C. H. M. (Contributor), Walenkamp-Hageman, A. (Contributor), Nienhuis, H. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), van Rooijen, J. (Contributor), Van Leeuwen-Stok, E. (Contributor), Schröder, C. (Contributor), Qiu, S. (Contributor), de Vries, L. (Contributor) & Timmer-Bosscha, H. (Contributor), University of Groningen, 31-Mar-2020
DOI: 10.6084/m9.figshare.12004494.v1, https://doi.org/10.6084%2Fm9.figshare.12004494.v1
Dataset
Press/Media
-
De ontwikkeling van FORCE, een landelijke infrastructuur om informatie over zeldzame tumoren te bundelen en toegankelijk te maken
01/07/2023
1 Media contribution
Press/Media: Public Engagement Activities › Professional
-
‘Zonder stok achter de deur was ik eerder gestopt’
15/12/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
‘Twee weken na de chemo kon ik weer fulltime aan het werk’
25/11/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Exercise During Chemo Shows Benefits for Cardiorespiratory Fitness
21/11/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Exercise During Chemo May Help You Beat the Treatment’s Effects
02/11/2022
2 items of Media coverage
Press/Media: Expert Comment › Popular
Prizes
-
UMCG Awarded ENETS Center of Excellence for Tumorgroup NET/NEC
Walenkamp-Hageman, A. (Recipient), 2022
Prize: Other distinction › Professional
-
Infrastructural grant FORCE; Infrastructure for rare cancer in the Netherlands (€3.200.000,--)
Walenkamp-Hageman, A. (Recipient), 2021
Prize: Other distinction › Academic
-
Educational grant IPSEN: “Multi-disciplinary website to inform patients with neuroendocrine tumors”. PI. (€50.000,--)
Walenkamp-Hageman, A. (Recipient), 2020
Prize: Other distinction › Academic
-
Grant: UMCG Cancer Researchfund: “Non-invasive evaluation of oxidative muscle metabolism in patients with testicular cancer enrolled in the UMCG ACT trial” (€3.000,--)
Walenkamp-Hageman, A. (Recipient), 2020
Prize: Other distinction › Academic
-
Educational grant IPSEN: “Multi-disciplinary approach in neuroendocrine tumor patients”. PI. (€200.000,--)
Walenkamp-Hageman, A. (Recipient), 2017
Prize: Other distinction › Academic